+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bovine Tuberculosis Diagnosis Market - Global Forecast to 2030- Product Image
Bovine Tuberculosis Diagnosis Market - Global Forecast to 2030- Product Image
Sale

Bovine Tuberculosis Diagnosis Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011093
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bovine Tuberculosis Diagnosis Market grew from USD 887.85 million in 2024 to USD 960.80 million in 2025. It is expected to continue growing at a CAGR of 7.83%, reaching USD 1.39 billion by 2030.

Bovine tuberculosis (bTB) remains a persistent challenge to animal health, agricultural productivity, and public well-being worldwide. Caused by Mycobacterium bovis, this insidious pathogen not only undermines livestock performance but also poses zoonotic risks to humans through direct contact or consumption of contaminated dairy products. Over the last decade, diagnostic capabilities have evolved dramatically, driven by the imperative to implement timely interventions and uphold biosecurity standards in both high- and low-income regions. As regulatory frameworks tighten and stakeholder expectations rise, the pressure on veterinary services and diagnostic providers to deliver rapid, reliable, and cost-effective testing solutions has never been greater.

Against this backdrop, this executive summary distills critical insights into diagnostic methodologies, market dynamics, regulatory influences, and strategic imperatives for industry leaders. By examining transformative shifts, tariff impacts, segmentation trends, regional distinctions, and competitive positioning, it offers a roadmap to enhance surveillance, strengthen control measures, and support informed decision-making. This analysis serves as a guide for veterinarians, laboratory managers, policymakers, and commercial stakeholders seeking to navigate the evolving terrain of bTB diagnosis with confidence and foresight.

The sections ahead unpack key developments, assess current challenges, and propose actionable steps for optimizing diagnostic pathways. By aligning technological innovation with market realities, stakeholders can sharpen their strategies to mitigate disease spread, safeguard animal populations, and fortify public health defenses.

Transformative Shifts in Diagnostic Technologies and Data Integration

The diagnostic landscape for bovine tuberculosis has undergone seismic shifts in recent years, catalyzed by advancements in molecular biology, digital imaging, and data analytics. Traditional skin tests, once the cornerstone of bTB surveillance, are increasingly complemented by culture methods that offer enhanced specificity. Meanwhile, enzyme-linked immunosorbent assays and molecular assays have propelled accuracy and throughput to new heights, enabling veterinarians to detect infections earlier and with greater confidence.

Moreover, the emergence of next-generation sequencing has opened avenues for unprecedented genetic resolution. By pinpointing strain variations through targeted or whole-genome sequencing, researchers can trace transmission pathways, monitor antimicrobial resistance markers, and tailor intervention strategies. Ultrasound and X-ray imaging, once confined to human diagnostics, are now finding niche applications in veterinary clinics for assessing granulomatous lesions in live animals, further reducing diagnostic lag.

Digital platforms and cloud-based analytics have also begun to transform case management, facilitating real-time data sharing among laboratories, research institutes, and regulatory bodies. This integration enhances outbreak response coordination and supports longitudinal studies on vaccine efficacy and disease prevalence. As these technologies mature, they promise to redefine best practices in bTB control and strengthen the global response to zoonotic threats.

Cumulative Impact of United States Tariffs on bTB Diagnostic Supply Chains

In 2025, United States tariffs on diagnostic imports have exerted a pronounced effect on the bTB testing ecosystem. Instruments sourced from leading manufacturers now carry added costs that reverberate across procurement budgets for veterinary clinics, diagnostic laboratories, and research institutes. With benchtop machines and handheld devices subject to higher duty rates, end users face difficult trade-offs between equipment affordability and feature-rich performance.

The imposition of tariffs on bulk kits, rapid test kits, and critical reagents such as antibodies and enzymes has further compressed margins for distributors and service providers. Many laboratories have responded by prioritizing local sourcing of consumables and exploring partnerships with domestic suppliers to circumvent cost escalations. At the same time, innovative reagent formulations that reduce assay volume requirements are gaining traction, offering a partial hedge against tariff-driven price increases.

Government research centers and academic institutions, historically reliant on international collaborations, are re-evaluating cross-border projects in light of added logistical and financial hurdles. These considerations extend to next-generation sequencing services, where targeted sequencing and whole-genome sequencing capabilities are often outsourced to global reference centers. As a result, stakeholders are advocating for policy recalibrations that balance domestic manufacturing incentives with the imperative to maintain access to best-in-class diagnostics.

Key Segmentation Insights Across Techniques, End Users, Products, and Applications

Diagnostic methodologies can be viewed through the prism of technique sophistication and adoption setting. Advanced imaging modalities such as ultrasound and X-ray, typically deployed in specialized veterinary facilities, complement culture and skin tests that form the backbone of traditional techniques. Within the modern suite, ELISA, molecular assays, and PCR approaches provide scalable platforms for high-volume screening, while the promise of next-generation sequencing-whether targeted or whole-genome-holds potential for genomic epidemiology.

End-user diversity further underscores the market’s complexity. Hospital labs and independent diagnostic laboratories drive demand for high-throughput instruments and automated molecular assays, whereas academic institutions and government research centers often lead in validating next-generation sequencing protocols. Veterinary clinics, segmented into government-run facilities and private practices, rely heavily on point-of-care diagnostics, favoring rapid kits and portable devices that deliver near-instant results in field settings.

Product segmentation reveals distinct procurement patterns. Instruments range from benchtop analyzers suited for centralized labs to handheld devices engineered for remote or on-farm testing. Bulk kits meet the needs of large diagnostic operators seeking economy of scale, while rapid kits cater to time-sensitive scenarios. Reagents such as antibodies and enzymes are foundational across all platforms, driving ongoing investment in supply chain resilience and quality control.

Applications cut across animal testing workflows, whether routine screening in dairy herds, slaughterhouse inspection protocols, sporadic outbreak investigations, or targeted surveillance in wildlife populations. These diverse use cases demand a flexible diagnostic portfolio capable of adapting to variable sample volumes, environmental conditions, and regulatory requirements.

Key Regional Dynamics Shaping Market Adoption and Collaboration

North America remains a critical hub for bTB diagnostic innovation, leveraging robust veterinary infrastructure, strong government research funding, and a network of diagnostic laboratories that span hospital and independent facilities. In contrast, Europe, the Middle East, and Africa present a tapestry of regulatory environments where disease prevalence, resource allocation, and biosecurity protocols vary widely. Leading markets in Western Europe have advanced assay validation frameworks, while emerging economies in the region are accelerating adoption of portable, point-of-care solutions to overcome infrastructure gaps.

Asia-Pacific illustrates dynamic growth trajectories, driven by expanding livestock populations, rising awareness of zoonotic disease risks, and government-led programs that incentivize local manufacturing of diagnostic consumables. Research institutes in academic institutions and government centers play a pivotal role in custom assay development, collaborating with private clinics to pilot field diagnostics in remote areas. Across these regions, strategic partnerships between reagent suppliers, instrument manufacturers, and end users are shaping the future of bTB surveillance through co-development of tailored solutions that address specific epidemiological challenges.

Key Competitive Insights from Leading Industry Players

Leading players are deploying multifaceted strategies to capture market share, optimize supply chains, and foster innovation. AsureQuality Australia Pty Ltd. and Bionote USA Inc. are differentiating through bespoke reagent development, while Becton, Dickinson and Company focuses on expanding its portfolio of handheld and benchtop instruments. Meanwhile, Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc. strengthen their molecular assay offerings by investing in reagent quality and workflow automation.

BioMerieux S.A. and F. Hoffmann-La Roche AG are leveraging their global distribution networks to mitigate tariff impacts, ensuring uninterrupted access to bulk kits and rapid kits for diagnostic laboratories. Boehringer Ingelheim GmbH and Zoetis Inc. collaborate with veterinary clinics to integrate diagnostic services into herd health management programs, enhancing disease monitoring at the farm level. IDEXX Laboratories, Inc. distinguishes itself with cloud-enabled data platforms that streamline case reporting and longitudinal analysis.

Innovative biotech firms such as PBD Biotech Ltd. and Lionex GmbH are pioneering next-generation sequencing workflows, targeting both targeted sequencing and whole-genome approaches to unravel pathogen dynamics. CZ Vaccines S.A.U. and Pall Corporation concentrate on refining fluidic systems and consumable design to boost assay reproducibility. Collectively, these companies are shaping a competitive landscape defined by technological leadership, regulatory agility, and customer-centric service models.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize the integration of rapid, point-of-care diagnostics with centralized laboratory workflows to balance speed and accuracy. Investing in modular platforms that support both molecular assays and immunoassays will enhance operational agility and reduce total cost of ownership. Collaborations between instrument manufacturers and reagent suppliers can yield co-optimized kits, streamlining validation processes and accelerating time-to-market.

Building strategic alliances with local research institutes and government centers can mitigate the effects of geopolitical disruptions, including tariffs and supply chain constraints. In parallel, companies should expand cloud-based data management tools to facilitate real-time surveillance and predictive analytics, enabling proactive outbreak management. Joint ventures or co-development agreements in Asia-Pacific and EMEA regions can unlock access to emerging end-user segments, particularly private and governmental veterinary clinics.

A focus on workforce training and certification programs will reinforce diagnostic quality and foster trust among end users. By supporting continuous education on advanced imaging, molecular techniques, and sequencing workflows, industry players can differentiate their offerings through service excellence. Finally, embedding sustainability principles in reagent manufacturing and instrument design will resonate with regulatory bodies and socially conscious stakeholders, positioning organizations as responsible leaders in animal health diagnostics.

Conclusion: Navigating the Complexities of bTB Diagnostic Market

The evolving landscape of bovine tuberculosis diagnosis underscores the imperative for agile, technology-driven solutions that address both traditional screening requirements and the advanced needs of genomic epidemiology. By aligning diagnostic portfolios with the nuanced demands of diverse end users-from high-volume hospital laboratories to remote field clinics-stakeholders can bolster disease control efforts and enhance animal welfare.

Strategic investments in platform interoperability, data integration, and local partnerships will not only insulate organizations against regulatory and tariff-related disruptions but also foster sustainable growth. As companies refine their value propositions around speed, accuracy, and cost efficiency, they will better serve the global push to eliminate bTB and safeguard public health. This synthesis of technical innovation, market intelligence, and actionable strategy provides a blueprint for navigating the complexities of the bTB diagnostic arena.

Market Segmentation & Coverage

This research report categorizes the Bovine Tuberculosis Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Advanced Imaging
    • Ultrasound
    • X-Ray
  • Future Techniques
    • Next-Generation Sequencing
      • Targeted Sequencing
      • Whole Genome Sequencing
  • Modern Techniques
    • ELISA
    • Molecular Assays
    • PCR
  • Traditional Techniques
    • Culture Method
    • Skin Test
  • Diagnostic Laboratories
    • Hospital Labs
    • Independent Labs
  • Research Institutes
    • Academic Institutions
    • Government Research Centers
  • Veterinary Clinics
    • Government Facilities
    • Private Clinics
  • Instruments
    • Benchtop Machines
    • Handheld Devices
  • Kits
    • Bulk Kits
    • Rapid Kits
  • Reagents
    • Antibodies
    • Enzymes
  • Animal Testing
  • Field Diagnostics
  • Slaughterhouse Testing
  • Sporadic Testing

This research report categorizes the Bovine Tuberculosis Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bovine Tuberculosis Diagnosis Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AsureQuality Australia Pty Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Bionote USA Inc.
  • Boehringer Ingelheim GmbH
  • CZ Vaccines S.A.U.
  • Enfer Group
  • F. Hoffmann-La Roche AG
  • IDEXX Laboratories, Inc.
  • Lionex GmbH
  • Pall Corporation
  • PBD Biotech Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bovine Tuberculosis Diagnosis Market, by Diagnostic Techniques
8.1. Introduction
8.2. Advanced Imaging
8.2.1. Ultrasound
8.2.2. X-Ray
8.3. Future Techniques
8.3.1. Next-Generation Sequencing
8.3.1.1. Targeted Sequencing
8.3.1.2. Whole Genome Sequencing
8.4. Modern Techniques
8.4.1. ELISA
8.4.2. Molecular Assays
8.4.3. PCR
8.5. Traditional Techniques
8.5.1. Culture Method
8.5.2. Skin Test
9. Bovine Tuberculosis Diagnosis Market, by End Users
9.1. Introduction
9.2. Diagnostic Laboratories
9.2.1. Hospital Labs
9.2.2. Independent Labs
9.3. Research Institutes
9.3.1. Academic Institutions
9.3.2. Government Research Centers
9.4. Veterinary Clinics
9.4.1. Government Facilities
9.4.2. Private Clinics
10. Bovine Tuberculosis Diagnosis Market, by Product Types
10.1. Introduction
10.2. Instruments
10.2.1. Benchtop Machines
10.2.2. Handheld Devices
10.3. Kits
10.3.1. Bulk Kits
10.3.2. Rapid Kits
10.4. Reagents
10.4.1. Antibodies
10.4.2. Enzymes
11. Bovine Tuberculosis Diagnosis Market, by Applications
11.1. Introduction
11.2. Animal Testing
11.3. Field Diagnostics
11.4. Slaughterhouse Testing
11.5. Sporadic Testing
12. Americas Bovine Tuberculosis Diagnosis Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Bovine Tuberculosis Diagnosis Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Bovine Tuberculosis Diagnosis Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AsureQuality Australia Pty Ltd.
15.3.2. Becton, Dickinson and Company
15.3.3. Bio-Rad Laboratories, Inc.
15.3.4. BioMerieux S.A.
15.3.5. Bionote USA Inc.
15.3.6. Boehringer Ingelheim GmbH
15.3.7. CZ Vaccines S.A.U.
15.3.8. Enfer Group
15.3.9. F. Hoffmann-La Roche AG
15.3.10. IDEXX Laboratories, Inc.
15.3.11. Lionex GmbH
15.3.12. Pall Corporation
15.3.13. PBD Biotech Ltd.
15.3.14. Takara Bio Inc.
15.3.15. Thermo Fisher Scientific Inc.
15.3.16. Zoetis Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET MULTI-CURRENCY
FIGURE 2. BOVINE TUBERCULOSIS DIAGNOSIS MARKET MULTI-LANGUAGE
FIGURE 3. BOVINE TUBERCULOSIS DIAGNOSIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BOVINE TUBERCULOSIS DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CULTURE METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SKIN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GOVERNMENT FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BENCHTOP MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BULK KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RAPID KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ANIMAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FIELD DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SLAUGHTERHOUSE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SPORADIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 103. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 104. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 105. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 106. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 107. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 108. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 109. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 110. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 111. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 112. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 113. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 114. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 116. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 117. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 169. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 180. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 181. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 182. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 183. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 184. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 185. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 186. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 187. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 188. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 189. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 190. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 191. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 192. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 193. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 194. CHINA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 195. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 196. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 197. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 198. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 199. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 200. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 201. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 202. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 203. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 204. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 205. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 206. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 208. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 209. INDIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 211. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 212. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 213. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 214. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 225. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 226. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 227. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 228. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 229. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 230. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 231. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 232. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 233. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 234. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 235. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 236. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 238. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 239. JAPAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 240. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 241. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 242. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 243. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 244. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 273. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 274. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 285. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 286. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 287. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 289. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY MODERN TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 290. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TRADITIONAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 291. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 300. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 301. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY ADVANCED IMAGING, 2018-2030 (USD MILLION)
TABLE 302. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY FUTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 303. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 304. TAIWAN BOVINE TUBERCULOSIS DIAGNOSIS

Companies Mentioned

  • AsureQuality Australia Pty Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Bionote USA Inc.
  • Boehringer Ingelheim GmbH
  • CZ Vaccines S.A.U.
  • Enfer Group
  • F. Hoffmann-La Roche AG
  • IDEXX Laboratories, Inc.
  • Lionex GmbH
  • Pall Corporation
  • PBD Biotech Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Bovine Tuberculosis Diagnosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032 - Product Image

Bovine Tuberculosis Diagnosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

  • Report
  • 174 Pages
  • Global
From
Bovine Tuberculosis Diagnosis - Global Strategic Business Report - Product Image

Bovine Tuberculosis Diagnosis - Global Strategic Business Report

  • Report
  • 183 Pages
  • Global
From
Bovine Tuberculosis Diagnosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Bovine Tuberculosis Diagnosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Zoonotic Tuberculosis. Mycobacterium bovis and Other Pathogenic Mycobacteria. Edition No. 3 - Product Image

Zoonotic Tuberculosis. Mycobacterium bovis and Other Pathogenic Mycobacteria. Edition No. 3

  • Book
  • 432 Pages
Cattle Health Market by Product Type, End User, Cattle Type, Disease Type, Treatment Method - Global Forecast 2025-2030 - Product Image

Cattle Health Market by Product Type, End User, Cattle Type, Disease Type, Treatment Method - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From

About the Bovine Tuberculosis Diagnosis Market

The Bovine Tuberculosis (TB) Diagnosis market is a segment of the Animal Healthcare/Veterinary industry. It focuses on the diagnosis and treatment of TB in cattle, which is a major cause of economic losses in the livestock industry. Diagnosis of TB in cattle is typically done through a combination of clinical signs, laboratory tests, and post-mortem examination. Tests used to diagnose TB in cattle include the single intradermal comparative cervical tuberculin test, the single intradermal comparative cervical tuberculin test with gamma interferon, and the single intradermal comparative cervical tuberculin test with gamma interferon and ELISA. The Bovine Tuberculosis Diagnosis market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include IDEXX Laboratories, Inc., Neogen Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Zoetis, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.